Future Market Insights (FMI), a leading market research firm, forecasts a promising future for the Global Anti-Adhesion Barrier Gels Industry. According to their latest study, the market is poised for significant growth, with a projected Compound Annual Growth Rate (CAGR) of nearly 8.4% throughout the forecast period. This positive outlook translates to an anticipated market valuation of US$209.8 million by 2032, reflecting a substantial increase from its current worth of US$93.4 million in 2022.
The FDA in the United States acknowledges that adhesion barriers are essential components of medical implants because they keep internal tissues and organs apart during healing and recovery from surgery. These barriers are primarily used to reduce aberrant internal scarring, also known as adhesions. Because of their critical function in reducing problems, anti-adhesion barrier products are now considered essential components in various surgical procedures.
Commercially available anti-adhesion materials are composed of sodium hyaluronate, Carboxymethylcellulose, or even oxidized regenerated cellulose. As adhesion barriers, such as hyaluronic acid, have the highest penetration rate in orthopedic procedures. A consistent rise in the number of patients undergoing fracture repair surgery and, coronary artery bypass grafting is expected to drive the demand for these products across the globe.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15678
During surgeries such as abdominal surgery, adhesion formation is a very common complication, wherein more than 90% of the patients develop intra-abdominal adhesions post-surgery. This leads to issues like infertility, small bowel obstruction, pelvic pain, etc. Moreover, many times, there are readmissions about these issues while many require further surgery which raises the difficulty and duration of these surgeries, thereby affecting patient’s quality of life significantly.
The use of cutting-edge technologies by surgeons to treat post-surgical adhesion has opened up new opportunities for pharmaceutical businesses to generate income. Since there is no specific medication available for the prevention of surgical adhesions, using adhesion barrier gels is an efficient strategy to lessen or avoid the incidence, extent, severity, and concerns of post-surgical adhesions.
Because adhesive barriers are the only treatment option for post-surgical adhesions, demand for adhesion barriers is anticipated to increase over the projected period.
Key Takeaways from the Global Anti-Adhesion Barrier Gels Industry Study
- Hyaluronic acid is the leading segment by product, and held a 2% market value share in 2021, owing to its usage in surgeries and sport-related injuries.
- Surgical Applications held a market share of 3% in 2021 owing to a rise in surgeries in different sectors such as cardiology, neurology, and others.
- By end user, hospitals are leading in the Global Anti-Adhesion Barrier Gels Industry, and are expected to continue to do so with a projected CAGR rate of 9% during the forecasted years.
- North America is considered the leading region with a value share of 5% in 2021, owing to the large number of manufacturers and growing patient pool in the region.
Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-15678
“Rising number surgical procedures along with growing demand for adhesion barriers post-surgery is set to propel the sales of anti-adhesion barrier gels across the globe,” says an analyst of Future Market Insights.
Market Competition
Investing in business inorganically has been the hallmark of bringing strong business growth and most players in the adhesion barriers market are following this trend, which directly contributes to revenue growth, increasing product portfolio, and expanding presence and distribution network in different geographies. The general competitive environment in the Global Anti-Adhesion Barrier Gels Industry is characterized by consolidation activities such as joint ventures and new product launches.
- On January 26, 2020, Terumo Launched New Surgical Sealant AQUABRID® in EMEA Market.
- In Jan 2017, Terumo acquired brands from Abbott Laboratories. The two brands namely Angio-Seal and FemoSeal, vascular closure devices are expected to boost Terumo’s existing product portfolio in growing segments through both in-house development and external investment
Global Anti-Adhesion Barrier Gels Industry Key Players:
- LG Chem Life Sciences Company
- Anika Therapeutics
- FzioMed, Inc.
- Normedi Nordic
- Betatech
- Bioscompass
- Klas
- Terumo
- BioRegen Biomedical
- CGBIO
- Shing Poong Pharma Co.LTD
- Hangzhou Singclean Medical Products Co., Ltd.
- General
- Kieron
- Hanohai Biological
- PlantTec Medical GmbH
Grab Your Discount Now Before It’s Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-15678
Key Market Segments Covered in the Global Anti-Adhesion Barrier Gels Industry Research
By Product:
- Hyaluronic acid
- Carboxymethylcellulose
- polyethylene oxides
By Application:
- Surgical Applications
- Urological & Gynecological Surgeries
- Orthopedic Surgeries
- Abdominal surgeries
- Neurological Surgeries
- Cardiovascular Surgeries
- Reconstructive and Plastic Surgeries
- Others
- Trauma Cases
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
